semaglutide vs tirzepatide weight loss results as Compared with for the Treatment of Obesity Tirzepatide Vs. Semaglutide: Which Is
Description
The finding matters because it reframes the question
Weight loss at 48 weeks was clearly dose-dependent
Additionally, women of childbearing potential should be advised that tirzepatide may cause fetal harm and should use effective contraception during treatment
Public awareness of GLP-1 medications has also surged in recent years, with about 91% of respondents in 2026 reporting they knew the drugs could treat weight lossup from 80% in 2024
